A recent Xconomy article “Biotech on a Shoestring” reflects an industry landscape change where, “the era of free-spending is supposedly out, and austerity is the watchword.” An emphasis on a heightened form of frugality can certainly save dollars but can also create uncertainty and anxiety amongst the rank and file. The inevitable next question arises … Continue reading “Biotech on a Shoestring? There’s a Better Way”
Author: Steve Speer
Steve Speer is a Carlsbad, CA-based biotechnology professional with 20-plus years in the industry. Having held manufacturing, operations and quality positions at some of the premier firms in the industry (Gen-Probe, Chiron and Life Technologies), Steve brings diverse perspectives and insights gained from his long tenure within the biotechnology arena. Steve can be contacted via LinkedIn or [email protected].